Research Peptide Glossary: Key Terms A-Z

This research peptide glossary defines the terminology researchers encounter when reviewing certificates of analysis, planning in-vitro assays, or reading the primary literature on peptide signaling. Whether you are parsing a receptor-binding paper or handling a lyophilized preparation at the bench, a shared vocabulary keeps documentation precise and reproducible. The definitions below are organized A-Z and written strictly for laboratory and preclinical research contexts. For the broader framework, see our pillar resource, Research Peptides: The Complete Lab Guide.

Research Use Only (RUO) disclaimer: All peptides referenced here are supplied for laboratory research use only. They are not for human or veterinary use, are not evaluated by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing in this glossary constitutes medical, dosing, or therapeutic guidance. All handling references apply to in-vitro and preclinical research preparations only.

Core Terms A-Z

Agonist

A ligand that binds a receptor and activates it, producing a downstream signaling response. In peptide research, many sequences act as agonists at G-protein-coupled receptors (GPCRs) — for example, growth-hormone secretagogue receptor (GHSR) ligands studied in preclinical models. A full agonist elicits a maximal response; a partial agonist produces a submaximal response even at receptor saturation. Contrast with antagonist.

Amino acid sequence

The ordered chain of amino acid residues defining a peptide's primary structure, conventionally written N-terminus to C-terminus using one- or three-letter codes. Sequence identity is what mass spectrometry and HPLC on a certificate of analysis are meant to confirm.

Antagonist

A ligand that binds a receptor without activating it, blocking or dampening the response an agonist would produce. Antagonists are widely used as research tools to probe which receptor mediates an observed effect in a model system.

Bioavailability

In pharmacokinetics, the fraction of an administered compound that reaches systemic circulation intact. For research peptides, low oral bioavailability is a common characteristic studied in preclinical models because gastrointestinal proteases and first-pass metabolism degrade many peptide sequences — a key reason parenteral routes dominate the research literature.

COA (Certificate of Analysis)

A third-party analytical document reporting the identity and purity of a specific production lot. A rigorous COA typically includes HPLC purity (e.g., ≥99%), mass spectrometry confirming molecular weight, and screens for residual solvents, endotoxin, or heavy metals. Every NeuroLabs preparation is third-party COA-tested — you can review lot documentation on our COA page. Reviewing the COA before an experiment is fundamental to reproducibility.

DAC (Drug Affinity Complex)

A structural modification that attaches a moiety enabling reversible binding to serum albumin, dramatically extending a peptide's circulating half-life in research models. The classic example is CJC-1295 with DAC, where the DAC extension turns a short-acting sequence into one with a substantially longer plasma residence time. We cover the chemistry in depth in DAC Technology: Extending Peptide Half-Life.

Downregulation

A reduction in receptor number or sensitivity, often following sustained agonist exposure. Studying downregulation and receptor desensitization is central to understanding why continuous stimulation can blunt a response over time in cell and animal models.

EC50

The concentration of an agonist producing 50% of its maximal effect — a standard measure of potency in dose-response assays. A lower EC50 indicates higher potency. Reported alongside IC50 (the analogous half-maximal inhibitory concentration) for antagonists.

Half-life (t½)

The time required for the concentration of a compound to fall by half. Peptide half-lives vary enormously — from minutes for unmodified sequences to days for albumin-binding or DAC-modified analogs. Half-life governs how frequently a signal is sustained in an experimental model. See Peptide Half-Life & Kinetics in Research for the full treatment.

HPLC (High-Performance Liquid Chromatography)

The primary analytical technique for quantifying peptide purity. Sample components separate as they pass through a column, and the resulting chromatogram allows the main peak (the target peptide) to be measured against impurities — the basis of the "≥99% purity" figure on a COA.

Ligand

Any molecule that binds a specific target such as a receptor or enzyme. Peptides frequently function as endogenous or synthetic ligands; binding affinity is often expressed as a dissociation constant (Kd).

Lyophilized

Freeze-dried. Peptides are commonly supplied as a lyophilized powder because removing water improves stability and shelf life. In the lab, a lyophilized research preparation is reconstituted with an appropriate sterile diluent before use in assays. Handling lyophilized material under low humidity helps preserve integrity.

Molecular weight (MW)

The mass of the peptide, reported in daltons (Da). Mass spectrometry on a COA confirms the observed MW matches the theoretical value for the stated sequence — a core identity check. MW is also used to convert between mass and molar concentration when preparing stock solutions.

Peptide bond

The covalent amide linkage joining the carboxyl group of one amino acid to the amino group of the next. Chains of roughly 2-50 residues are termed peptides; longer chains are proteins. Peptide bonds are the backbone target of the proteases that limit peptide half-life.

Purity

The percentage of a preparation that is the intended peptide, versus truncated sequences, deletion products, or process residues. Higher purity reduces experimental variability from unidentified contaminants. NeuroLabs specifies ≥99% purity, verified by third-party HPLC.

Receptor

A protein — often membrane-bound — that binds a ligand and transduces a signal into the cell. GPCRs are the largest receptor family relevant to peptide research. For a primer on how binding becomes a cellular response, see How Peptides Work: Receptor Signaling Basics.

Reconstitution

The laboratory process of dissolving a lyophilized peptide in a suitable diluent (commonly bacteriostatic or sterile water for research preparations) to produce a working stock. Gentle swirling rather than vigorous shaking helps avoid shearing sensitive sequences; the reconstituted stock is then aliquoted and stored per stability guidance.

Secretagogue

A substance that stimulates secretion from a gland or cell. Growth-hormone secretagogues are a widely studied peptide class that act at GHSR to promote release of endogenous growth hormone in research models — a mechanism distinct from administering the hormone directly. Understanding the secretagogue mechanism is key to interpreting the relevant literature.

Sequence homology

The degree of similarity between two amino acid sequences, often used to infer shared function or evolutionary relationship. Analogs are frequently designed by modifying a parent sequence to alter stability or receptor selectivity while preserving core homology.

Stability

A peptide's resistance to degradation under given conditions of temperature, pH, and light. Stability determines storage requirements: many lyophilized peptides are stored frozen long-term, while reconstituted stocks are typically refrigerated and used within a shorter window. Freeze-thaw cycling is generally minimized to preserve integrity.

Systemic

Affecting the whole organism rather than a localized site — a term used when describing distribution and pharmacokinetics in preclinical animal models, as opposed to localized in-vitro exposure.

Quick-reference table

Applying the vocabulary

These terms recur across nearly every research peptide datasheet. When evaluating a preparation such as BPC-157 (10mg), a researcher reads the sequence and molecular weight to confirm identity, checks HPLC purity and the COA for lot quality, notes that the material ships lyophilized, and plans reconstitution and storage around its stability. For a longer-acting analog like CJC-1295 with DAC, the DAC modification and extended half-life shape how a time-course study in a model system is designed. To see how these terms map across our full range, browse the NeuroLabs Research Peptide Catalog Overview, and if you are new to the field start with Research Peptides 101: What They Are.

Keeping this vocabulary precise supports the reproducibility that rigorous preclinical work depends on. Bookmark this glossary as a reference alongside the pillar guide, and consult a preparation's COA before every experiment.